Approvals/NMPA/Beclometasone Dipropionate and Formoterol Fumarate Powder for Inhalation

Approved

化学药品

Beclometasone Dipropionate and Formoterol Fumarate Powder for Inhalation

CHIESI FARMACEUTICI S.P.A.🇨🇳 National Medical Products Administration

Approval Id: 8f3kqVNcKuP
Approval Number: 国药准字HJ20240144
Generic Name: 倍氯米松福莫特罗吸入粉雾剂
Generic Name En: Beclometasone Dipropionate and Formoterol Fumarate Powder for Inhalation
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每个吸入器120吸，每吸含丙酸倍氯米松100μg和富马酸福莫特罗6μg，递送剂量为丙酸倍氯米松81.9μg和富马酸福莫特罗5.0μg。
Reg Date: 2024-12-01
Expired Date: 2029-11-30
Company Name: CHIESI FARMACEUTICI S.P.A.
Production Company Name: CHIESI FARMACEUTICI S.P.A.
Company Detail Path: /organization/chiesi-farmaceutici-s-p-a
Production Company Detail Path: /organization/chiesi-farmaceutici-s-p-a

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 1, 2024

Approval ID

8f3kqVNcKuP

Type

化学药品